Iddo Leshem commenced his role as General Manager, Bristol Myers Squibb (BMS) Nordics in January 2018.
The Nordics’ business has over 200 employees and Iddo will be based at BMS’s Swedish office in Solna, Stockholm.
“Our mission is to translate cutting edge science into innovative medicines that extend and improve lives of patients combating serious diseases. In recent years we have launched a series of new drugs, in particular in the areas of immuno-oncology and heart disease, which have created new opportunities for healthier and longer lives for thousands of patients. The Nordic countries have a long history of providing high quality healthcare to their citizens and we look forward to working with health authorities in order to make more innovative treatments available as fast as possible. That is our promise to patients”, says Iddo Leshem, General Manager Nordics at Bristol-Myers Squibb.
Iddo Leshem studied bio-technology at Tel Aviv University and the Weizmann Institute of Science and has undertook an MBA at INSEAD. Iddo’s most recent role was in BMS’s headquarters in New Jersey where he was global commercial director for Opdivo, one of BMS’s immuno-oncology products. Amongst his previous roles, Iddo was also Country Manager for BMS in Israel.
